Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
June 14, 2022
Monkeypox has been around for decades, but it has been low priority for global and public health, despite a notable reemergence of the disease in West and Central Africa in 2017. Now, as the virus reaches 35 countries outside the West and Central African regions, the disease’s current dynamics are s...
Blog Post
June 10, 2022
In June 2021, Dr. Tedros Ghebreyesus, offered a challenge to the world: “To truly end the pandemic, our goal must be to vaccinate at least 70 percent of the world’s population by the time you meet again in Germany next year.” However, as we approach this year’s G7 summit, the 70 percent target has b...
Blog Post
May 26, 2022
Yesterday at the annual World Health Assembly in Geneva, member states passed a resolution tabled by the Argentina, Peru, and the UK that aims to strengthen clinical trials to improve public health. As COVID-19 has made abundantly clear, the evidence generated by high-quality clinical trials is esse...
REPORTS
May 12, 2022
To hear talk of it, you might think educating girls is a silver bullet to solve all the world’s ills. A large and still growing collection of research demonstrates the wide-ranging benefits of girls’ education. Recent research has nuanced some of those findings, but the fundamental result stands: Ed...
Blog Post
May 12, 2022
Girls today are getting more education than ever before. But many girls are still being left behind. How can societies ensure they go the last mile when it comes to guaranteeing all girls have access to primary school, or the last hundred miles when it comes to quality education and access to second...
BRIEFS
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.
Blog Post
April 28, 2022
In the past two years, we have all learned that the end of a COVID-19 wave is the end of a chapter, not the end of the story. Ongoing COVID transmission means the risk of new variants of pandemic potential is ever present and vaccination remains our best defence. The primary near-term challenges for...
BRIEFS
April 28, 2022
COVID-19 radically changed most people’s lives in 2020, including across Africa. In Ethiopia, the disruption started with school closing, and other restrictions soon followed. Despite these efforts to contain the virus, Ethiopia—like almost all countries—suffered significant health impacts. It has r...
Blog Post
April 28, 2022
CGD's Lee Crawfurd and Aisha Ali make the case for free secondary education, arguing that experiences of free primary education shows how free secondary education could work. And Robert Osei and Kwabena Adu-Ababio say free school is pro-poor for countries that can afford it. But Cambridge University...